Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiao-Zhong Chen

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Oncology Research|September 9, 2014
A phase II trial of Endostar combined with gemcitabine and cisplatin chemotherapy in patients with metastatic nasopharyngeal carcinoma (NCT01612286)Ting Jin, Bin Li, Xiao-Zhong Chen
Oncology Letters|December 2, 2015
Evaluation of the efficacy and safety of a neoadjuvant gemcitabine and nedaplatin regimen followed by radiotherapy or concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinomaTing Jin, Xiao-Zhong Chen, Jian-Jiang Liu
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|September 12, 2017
[Bioactive lignans from Silybum marianum]Yan Zhang, Yu-Bo Peng, Xiao-Zhong Chen, et al.
Chinese Journal of Cancer|October 14, 2016
ABO blood group is a predictor of survival in patients with laryngeal cancerTing Jin, Pei-Jing Li, Xiao-Zhong Chen, et al.
Japanese Journal of Clinical Oncology|February 12, 2016
Repeat biopsy of primary disease negatively affects the outcome of patients with nasopharyngeal cancer treated with definitive intensity-modified radiotherapy: a cohort analysis of 795 patientsFeng Jiang, Ting Jin, Xing-Lei Feng, et al.
Translational Oncology|February 8, 2018
Endostar Combined with Gemcitabine and Cisplatin Chemotherapy for Patients with Metastatic Nasopharyngeal Carcinoma: an UpdateTing Jin, Feng Jiang, Qi-Feng Jin, et al.
Translational Cancer Research|February 4, 2022
Apatinib in treating patients with recurrent or metastatic nasopharyngeal carcinoma who had failed prior platinum-based chemotherapyChang-Juan Tao, Peng Zhang, Ling Zhou, et al.
Molecules (Basel, Switzerland)|June 26, 2015
Metabolites Produced by the Endophytic Fungus Aspergillus fumigatus from the Stem of Erythrophloeum fordii OlivYu-Sheng Shi, Yan Zhang, Xiao-Zhong Chen, et al.
Journal of Cancer Research and Therapeutics|October 29, 2015
Long-term outcomes and failure patterns of patients with nasopharyngeal carcinoma staged by magnetic resonance imaging in intensity-modulated radiotherapy era: The Zhejiang Cancer Hospital's experienceFeng Jiang, Ting Jin, Xing-Lei Feng, et al.
Translational Oncology|December 20, 2020
Anti-PD1 checkpoint inhibitor with or without chemotherapy for patients with recurrent and metastatic nasopharyngeal carcinomaTing Jin, Qun Zhang, Qi-Feng Jin, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Oncology Research|September 9, 2014
A phase II trial of Endostar combined with gemcitabine and cisplatin chemotherapy in patients with metastatic nasopharyngeal carcinoma (NCT01612286)Ting Jin, Bin Li, Xiao-Zhong Chen
Oncology Letters|December 2, 2015
Evaluation of the efficacy and safety of a neoadjuvant gemcitabine and nedaplatin regimen followed by radiotherapy or concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinomaTing Jin, Xiao-Zhong Chen, Jian-Jiang Liu
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|September 12, 2017
[Bioactive lignans from Silybum marianum]Yan Zhang, Yu-Bo Peng, Xiao-Zhong Chen, et al.
Chinese Journal of Cancer|October 14, 2016
ABO blood group is a predictor of survival in patients with laryngeal cancerTing Jin, Pei-Jing Li, Xiao-Zhong Chen, et al.
Japanese Journal of Clinical Oncology|February 12, 2016
Repeat biopsy of primary disease negatively affects the outcome of patients with nasopharyngeal cancer treated with definitive intensity-modified radiotherapy: a cohort analysis of 795 patientsFeng Jiang, Ting Jin, Xing-Lei Feng, et al.
Translational Oncology|February 8, 2018
Endostar Combined with Gemcitabine and Cisplatin Chemotherapy for Patients with Metastatic Nasopharyngeal Carcinoma: an UpdateTing Jin, Feng Jiang, Qi-Feng Jin, et al.
Translational Cancer Research|February 4, 2022
Apatinib in treating patients with recurrent or metastatic nasopharyngeal carcinoma who had failed prior platinum-based chemotherapyChang-Juan Tao, Peng Zhang, Ling Zhou, et al.
Molecules (Basel, Switzerland)|June 26, 2015
Metabolites Produced by the Endophytic Fungus Aspergillus fumigatus from the Stem of Erythrophloeum fordii OlivYu-Sheng Shi, Yan Zhang, Xiao-Zhong Chen, et al.
Journal of Cancer Research and Therapeutics|October 29, 2015
Long-term outcomes and failure patterns of patients with nasopharyngeal carcinoma staged by magnetic resonance imaging in intensity-modulated radiotherapy era: The Zhejiang Cancer Hospital's experienceFeng Jiang, Ting Jin, Xing-Lei Feng, et al.
Translational Oncology|December 20, 2020
Anti-PD1 checkpoint inhibitor with or without chemotherapy for patients with recurrent and metastatic nasopharyngeal carcinomaTing Jin, Qun Zhang, Qi-Feng Jin, et al.
Pageof 6